RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Boston, MA · Newton, MA · +42 more sites
2 recruiting lung cancer studies with a site in Newton, MA.
Sponsor: Pfizer
Boston, MA · Newton, MA · +42 more sites
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Boston, MA · +103 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.